• Influenza Hemagglutinin (HA) Peptide: Precision in Ubiquitin

  2026-05-21

  Explore the advanced role of Influenza Hemagglutinin (HA) Peptide in ubiquitination research and protein-protein interaction assays. This in-depth guide reveals how HA tag peptides drive rigor and innovation in molecular biology workflows.

• Digoxin in Translational Research: Mechanism, Models & New F

  2026-05-20

  This thought-leadership article explores the evolving role of Digoxin, a potent Na+/K+ ATPase pump inhibitor, in both cardiovascular and antiviral translational research. Integrating mechanistic insight, animal model data, and strategic protocol guidance, the piece offers a roadmap for researchers seeking to harness Digoxin’s dual activity in arrhythmia, heart failure, and chikungunya virus inhibition. The discussion advances beyond conventional product profiles, highlighting workflow considerations, cross-domain opportunities, and the competitive research landscape.

• ARCA EGFP mRNA: Precision Controls and Assay Optimization Un

  2026-05-20

  Explore how ARCA EGFP mRNA enables quantitative optimization of fluorescence-based transfection assays in mammalian cells. This article reveals deeper scientific strategies for maximizing assay reproducibility and integrating pathway insights, setting it apart from prior overviews.

• Blue Light Damages Skin Barrier via EGFR/ERK/c-Jun Pathway

  2026-05-19

  This study demonstrates that repeated blue light exposure disrupts human and mouse skin barrier integrity through activation of the EGFR/ERK/c-Jun signaling pathway. The findings provide new mechanistic insight into visible light-induced skin damage, highlighting molecular targets for mitigation strategies.

• Dabigatran and Its Metabolite: Comparative Anticoagulant Eff

  2026-05-19

  This study rigorously demonstrates that dabigatran acylglucuronide, the main metabolite of dabigatran, displays a significantly weaker anticoagulant effect than the parent compound. The findings refine understanding of dabigatran’s pharmacodynamics and have direct implications for both laboratory assay design and clinical monitoring of anticoagulant status.

• Rotavirus Infection Suppresses Nrf2 Antioxidant Pathways via

  2026-05-18

  This study reveals that progressive rotavirus infection leads to a marked downregulation of the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes, mediated by enhanced ubiquitin-proteasome degradation. These findings deepen our understanding of host-pathogen interactions and highlight the complexity of cellular stress responses during viral infection.

• RAB31 Defines an ESCRT-Independent Exosome Biogenesis Pathwa

  2026-05-18

  Wei et al. (2021) identify RAB31 as a critical regulator marking and controlling a previously uncharacterized ESCRT-independent exosome pathway. This discovery refines the mechanistic understanding of exosome formation and secretion, highlighting the dual roles of RAB31 in ILV formation and preventing MVE degradation.

• Cimetidine: Distinct H2 Antagonist for Cancer & Barrier Mode

  2026-05-17

  Cimetidine is a histamine-2 receptor antagonist with partial agonist activity, enabling unique mechanistic insights in cancer and blood-brain barrier research. Its verified solubility and high purity underpin reproducible in vitro protocols. APExBIO’s Cimetidine (SKU B1557) offers researchers a robust tool for dissecting H2 receptor signaling and antitumor activity.

• Lyso-Tracker Red: Enhanced Lysosome Labeling in Live Cancer

  2026-05-16

  Lyso-Tracker Red enables robust, high-specificity visualization of lysosomal dynamics in live cells, surpassing older dyes in selectivity and workflow reliability. Its integration into apoptosis and methuosis research unlocks new insights into drug synergy and lysosomal membrane permeability in cancer studies.

• Ferrostatin-1: Mastering Ferroptosis for Translational Impac

  2026-05-15

  Explore how Ferrostatin-1 (Fer-1) empowers translational researchers to mechanistically dissect and strategically inhibit ferroptosis. This thought-leadership piece bridges experimental rigor, mechanistic insight, and competitive innovation, while contextualizing recent advances in redox-targeted cancer therapy.

• RBMS1 Depletion Enhances Anti-Tumor Immunity in TNBC via PD-

  2026-05-15

  This study identifies RBMS1 as a key post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer (TNBC). By depleting RBMS1, the authors demonstrate enhanced anti-tumor immunity and improved efficacy of immune checkpoint blockade, providing a new avenue for immunotherapeutic strategies in immune-cold TNBC.

• Practical Guidance for Neuromedin S (rat) in GPCR Assays

  2026-05-14

  Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for reproducible activation of neuromedin U receptor signaling in controlled rat GPCR/G protein research. This product is intended solely for well-defined research protocols and should not be used in diagnostic, therapeutic, or clinical applications.

• PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration

  2026-05-14

  This study uncovers how hyperactivated endoplasmic reticulum stress (ERS) in nucleus pulposus cells drives pyroptosis and inflammation through a PERK-dependent JAK1–STAT3 signaling cascade. By dissecting these interconnected pathways, the authors highlight novel therapeutic targets for intervertebral disc degeneration and provide a mechanistic basis for precision ER stress research.

• METTL16-SENP3-LTF Axis Modulates Ferroptosis Resistance in H

  2026-05-13

  Wang et al. (2024) reveal that the METTL16-SENP3-LTF axis underpins ferroptosis resistance in hepatocellular carcinoma by linking m6A RNA modification to iron metabolism. This mechanistic insight offers new avenues for sensitizing tumors to ferroptosis-based therapies and guiding the development of novel molecular targeting strategies.

• Docetaxel in Cancer Chemotherapy Research: Advanced Workflow

  2026-05-13

  Docetaxel (Taxotere) is a cornerstone for probing cell cycle arrest, apoptosis, and chemoresistance in advanced cancer models. This guide delivers workflow-embedded insights, protocol enhancements, and troubleshooting know-how to empower researchers leveraging APExBIO’s trusted Docetaxel for robust, reproducible results.

16650 records 1/1110 page Next 12345 下5页 Last page